| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Johannes Rentzsch, Ada Stadtmann, Christiane Montag, Hagen Kunte, Doris Plöckl, Rainer Hellweg, Jürgen Gallinat, Golo Kronenberg, Maria Christiane Jockers-Scherüb. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. European archives of psychiatry and clinical neuroscience. vol 266. issue 5. 2017-02-03. PMID:26182894. |
attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. |
2017-02-03 |
2023-08-13 |
Not clear |
| Johannes Rentzsch, Ada Stadtmann, Christiane Montag, Hagen Kunte, Doris Plöckl, Rainer Hellweg, Jürgen Gallinat, Golo Kronenberg, Maria Christiane Jockers-Scherüb. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. European archives of psychiatry and clinical neuroscience. vol 266. issue 5. 2017-02-03. PMID:26182894. |
however, the relationship between cannabis use and schizophrenia is complex. |
2017-02-03 |
2023-08-13 |
Not clear |
| Johannes Rentzsch, Ada Stadtmann, Christiane Montag, Hagen Kunte, Doris Plöckl, Rainer Hellweg, Jürgen Gallinat, Golo Kronenberg, Maria Christiane Jockers-Scherüb. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. European archives of psychiatry and clinical neuroscience. vol 266. issue 5. 2017-02-03. PMID:26182894. |
in particular, little is known about the effects of chronic cannabis use on the attention-related electric brain response in schizophrenia. |
2017-02-03 |
2023-08-13 |
Not clear |
| Johannes Rentzsch, Ada Stadtmann, Christiane Montag, Hagen Kunte, Doris Plöckl, Rainer Hellweg, Jürgen Gallinat, Golo Kronenberg, Maria Christiane Jockers-Scherüb. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. European archives of psychiatry and clinical neuroscience. vol 266. issue 5. 2017-02-03. PMID:26182894. |
however, cannabis use may lead to different cognitive sequelae in patients with schizophrenia and in healthy controls, possibly reflecting preexisting alterations in the endocannabinoid system in schizophrenia. |
2017-02-03 |
2023-08-13 |
Not clear |
| Isobel W Green, Jill R Glausie. Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophrenia bulletin. vol 42. issue 3. 2017-01-17. PMID:26392629. |
to demonstrate the equifinal model, we discuss how maternal infection and adolescent cannabis use, 2 recognized schizophrenia risk factors, may interact with other genetic, environmental, and/or developmental risk factors to cause the conserved clinical presentation of impaired working memory. |
2017-01-17 |
2023-08-13 |
Not clear |
| Jason Schiffman, Ryan E Lawrence, Caroline Demro, Paul S Appelbaum, Lisa B Dixo. Attitudes towards cannabis use and genetic testing for schizophrenia. Early intervention in psychiatry. vol 10. issue 3. 2017-01-04. PMID:24957110. |
attitudes towards cannabis use and genetic testing for schizophrenia. |
2017-01-04 |
2023-08-13 |
Not clear |
| Jason Schiffman, Ryan E Lawrence, Caroline Demro, Paul S Appelbaum, Lisa B Dixo. Attitudes towards cannabis use and genetic testing for schizophrenia. Early intervention in psychiatry. vol 10. issue 3. 2017-01-04. PMID:24957110. |
for some individuals with specific genotypes, cannabis use may increase risk of schizophrenia. |
2017-01-04 |
2023-08-13 |
Not clear |
| Jason Schiffman, Ryan E Lawrence, Caroline Demro, Paul S Appelbaum, Lisa B Dixo. Attitudes towards cannabis use and genetic testing for schizophrenia. Early intervention in psychiatry. vol 10. issue 3. 2017-01-04. PMID:24957110. |
it is possible that genetic tests could be offered in the future to inform individuals of the risk of schizophrenia if they use cannabis. |
2017-01-04 |
2023-08-13 |
Not clear |
| Shaun M Eack, Susan S Hogarty, Srihari S Bangalore, Matcheri S Keshavan, Jack R Corneliu. Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study. Journal of dual diagnosis. vol 12. issue 1. 2017-01-03. PMID:27089154. |
this study examined the impact of cognitive remediation on alcohol and cannabis use and the cognitive correlates of changes in substance use among outpatients with schizophrenia. |
2017-01-03 |
2023-08-13 |
Not clear |
| F F Peres, M C Diana, M A Suiama, V Justi, V Almeida, R A Bressan, A W Zuardi, J E Hallak, J A Crippa, V C Abili. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. Schizophrenia research. vol 172. issue 1-3. 2016-12-27. PMID:26856781. |
peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. |
2016-12-27 |
2023-08-13 |
Not clear |
| David D Aguilar, Andrea Giuffrida, Daniel J Lodg. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia. Journal of psychopharmacology (Oxford, England). vol 30. issue 2. 2016-10-31. PMID:26510449. |
cannabis use has been associated with an increased risk to develop schizophrenia as well as symptom exacerbation in patients. |
2016-10-31 |
2023-08-13 |
rat |
| David D Aguilar, Andrea Giuffrida, Daniel J Lodg. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia. Journal of psychopharmacology (Oxford, England). vol 30. issue 2. 2016-10-31. PMID:26510449. |
such information is important for understanding why marijuana and synthetic cannabinoid use may be contraindicated in schizophrenia patients while endocannabinoid enhancement may provide a novel therapeutic approach. |
2016-10-31 |
2023-08-13 |
rat |
| David W Volk, David A Lewi. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26210060. |
cannabis use has been reported to increase the risk of developing schizophrenia and to worsen symptoms of the illness. |
2016-10-28 |
2023-08-13 |
human |
| David W Volk, David A Lewi. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26210060. |
both of these outcomes might be attributable to the disruption by cannabis of the endogenous cannabinoid system's spatiotemporal regulation of the inhibitory circuitry in the prefrontal cortex that is essential for core cognitive processes, such as working memory, which are impaired in schizophrenia. |
2016-10-28 |
2023-08-13 |
human |
| David W Volk, David A Lewi. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26210060. |
in addition, how interactions between these alterations in the endocannabinoid system and those in other inhibitory neurons in the prefrontal cortex in subjects with schizophrenia might increase the liability to adverse outcomes with cannabis use is considered. |
2016-10-28 |
2023-08-13 |
human |
| Patrick D Skosnik, Jose A Cortes-Briones, Mihály Hajó. It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26850792. |
in humans, studies examining the effects of chronic cannabis use (utilizing electroencephalography) have shown abnormalities in neural oscillations in a pattern similar to those observed in schizophrenia. |
2016-10-28 |
2023-08-13 |
Not clear |
| Romina Mizrah. Social Stress and Psychosis Risk: Common Neurochemical Substrates? Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 41. issue 3. 2016-10-06. PMID:26346639. |
we have chosen the latter two molecular pathways based on emerging evidence linking schizophrenia to altered neuroinflammatory processes and cannabis use. |
2016-10-06 |
2023-08-13 |
human |
| Christian Núñez, Susana Ochoa, Elena Huerta-Ramos, Iris Baños, Ana Barajas, Montserrat Dolz, Bernardo Sánchez, Núria Del Cacho, Judith Usal. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology. vol 233. issue 5. 2016-09-30. PMID:26621349. |
first episode patients and patients with schizophrenia exhibit increased rates of cannabis use compared to the general population. |
2016-09-30 |
2023-08-13 |
Not clear |
| Fernanda F Peres, Raquel Levin, Valéria Almeida, Antonio W Zuardi, Jaime E Hallak, José A Crippa, Vanessa C Abili. Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Frontiers in pharmacology. vol 7. 2016-09-26. PMID:27667973. |
cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the shr animal model: implications for schizophrenia pharmacotherapy. |
2016-09-26 |
2023-08-13 |
rat |
| Michael D Ballinger, Atsushi Saito, Bagrat Abazyan, Yu Taniguchi, Ching-Hsun Huang, Koki Ito, Xiaolei Zhu, Hadar Segal, Hanna Jaaro-Peled, Akira Sawa, Ken Mackie, Mikhail V Pletnikov, Atsushi Kamiy. Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory. Neurobiology of disease. vol 82. 2016-08-19. PMID:26093170. |
here we show for the first time that a perturbation in disrupted in schizophrenia 1 (disc1) exacerbates the response to adolescent exposure to delta-9-tetrahydrocannabinol (Δ(9)-thc), a major psychoactive ingredient of cannabis, consistent with the concept that gene-environment interaction may contribute to the pathophysiology of psychiatric conditions. |
2016-08-19 |
2023-08-13 |
mouse |